Friday, July 3 - A rumor circulating since June claims that U.S. President Donald Trump benefited from early and exclusive access to retatrutide, an anti-obesity drug still in the experimental stage, ...
Hosted on MSN
Did Trump get exclusive access to Eli Lilly's experimental weight loss drug? What we know
A rumor spread in June 2026 that U.S. President Donald Trump obtained early and exclusive access to the retatrutide weight loss drug — a medication by pharmaceutical company Eli Lilly so coveted that ...
A STAT News report said several clues pointed to the president being the unnamed 79-year-old man who received the drug.
Add Yahoo as a preferred source to see more of our stories on Google. Saul Loeb, accessed via Getty Images The claim that U.S. President Donald Trump may have had early and exclusive access to Eli ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results